Royce & Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,713
| Closed | -$3.93M | – | 902 |
|
|
2024
Q1 | $3.93M | Sell |
9,713
-787
| -7% | -$318K | 0.04% | 544 |
|
|
2023
Q4 | $3.22M | Buy |
+10,500
| New | +$3.22M | 0.03% | 577 |
|
|
2022
Q1 | – | Sell |
-15,000
| Closed | -$3.27M | – | 1000 |
|
|
2021
Q4 | $3.27M | Hold |
15,000
| – | – | 0.02% | 643 |
|
|
2021
Q3 | $2.84M | Sell |
15,000
-568
| -4% | -$108K | 0.02% | 691 |
|
|
2021
Q2 | $2.75M | Hold |
15,568
| – | – | 0.02% | 716 |
|
|
2021
Q1 | $2.55M | Sell |
15,568
-3,599
| -19% | -$590K | 0.02% | 718 |
|
|
2020
Q4 | $2.67M | Hold |
19,167
| – | – | 0.02% | 676 |
|
|
2020
Q3 | $2.14M | Hold |
19,167
| – | – | 0.02% | 666 |
|
|
2020
Q2 | $1.78M | Hold |
19,167
| – | – | 0.02% | 690 |
|
|
2020
Q1 | $1.41M | Hold |
19,167
| – | – | 0.02% | 676 |
|
|
2019
Q4 | $1.61M | Buy |
19,167
+556
| +3% | +$46.7K | 0.01% | 735 |
|
|
2019
Q3 | $1.56M | Buy |
18,611
+14,611
| +365% | +$1.23M | 0.01% | 747 |
|
|
2019
Q2 | $262K | Hold |
4,000
| – | – | ﹤0.01% | 976 |
|
|
2019
Q1 | $236K | Buy |
+4,000
| New | +$236K | ﹤0.01% | 991 |
|